{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=Alimera+Sciences", "query": { "sponsor": "Alimera Sciences" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=Alimera+Sciences&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-04T15:53:12.674Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00695318", "title": "Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Age-Related Macular Degeneration" ], "interventions": [ { "name": "Fluocinolone Acetonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alimera Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 17, "start_date": "2008-12", "completion_date": null, "has_results": true, "last_update_posted_date": "2015-05-29", "last_synced_at": "2026-10-04T15:53:12.674Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00695318" }, { "nct_id": "NCT00490815", "title": "Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "Fluocinolone Acetonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alimera Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 37, "start_date": "2007-08", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2014-02-13", "last_synced_at": "2026-10-04T15:53:12.674Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00490815" }, { "nct_id": "NCT02424019", "title": "Phase 4 IOP Signals Associated With ILUVIEN®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetic Macular Edema (DME)" ], "interventions": [ { "name": "ILUVIEN 0.19 MG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alimera Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 153, "start_date": "2015-05-06", "completion_date": "2020-07-31", "has_results": false, "last_update_posted_date": "2022-01-11", "last_synced_at": "2026-10-04T15:53:12.674Z", "location_count": 41, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Glendale, California + 36 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Glendale", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Mountain View", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02424019" }, { "nct_id": "NCT00770770", "title": "Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Macular Edema", "Retinal Vein Occlusion" ], "interventions": [ { "name": "Fluocinolone Acetonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alimera Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2009-05", "completion_date": null, "has_results": true, "last_update_posted_date": "2015-05-28", "last_synced_at": "2026-10-04T15:53:12.674Z", "location_count": 3, "location_summary": "Lexington, Kentucky • Boston, Massachusetts • Cleveland, Ohio", "locations": [ { "city": "Lexington", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00770770" }, { "nct_id": "NCT04469595", "title": "A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "Iluvien 0.19 MG Drug Implant", "type": "DRUG" }, { "name": "Aflibercept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alimera Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2020-08-31", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2024-07-31", "last_synced_at": "2026-10-04T15:53:12.674Z", "location_count": 40, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Beverly Hills, California + 36 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Laguna Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04469595" }, { "nct_id": "NCT00605423", "title": "The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Age Related Macular Degeneration" ], "interventions": [ { "name": "Fluocinolone Acetonide/Medidur", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 6, "start_date": "2008-01", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2014-04-07", "last_synced_at": "2026-10-04T15:53:12.674Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00605423" }, { "nct_id": "NCT00344968", "title": "Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "Fluocinolone Acetonide", "type": "DRUG" }, { "name": "Standard of care laser photocoagulation", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Alimera Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 956, "start_date": "2007-09", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2014-05-07", "last_synced_at": "2026-10-04T15:53:12.674Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00344968" }, { "nct_id": "NCT05322070", "title": "Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Uveitis, Posterior" ], "interventions": [ { "name": "Fluocinolone Acetonide Intravitreal Implant 0.18 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alimera Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2022-06-06", "completion_date": "2025-11", "has_results": false, "last_update_posted_date": "2024-08-06", "last_synced_at": "2026-10-04T15:53:12.674Z", "location_count": 23, "location_summary": "Fullerton, California • Glendale, California • Pasadena, California + 20 more", "locations": [ { "city": "Fullerton", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Lakewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05322070" }, { "nct_id": "NCT01998412", "title": "Iluvien Registry Safety Study", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Diabetic Macular Oedema Considered Insufficiently Responsive to Available Therapies" ], "interventions": [], "intervention_types": [], "sponsor": "Alimera Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 559, "start_date": "2013-12", "completion_date": "2020-01", "has_results": false, "last_update_posted_date": "2019-03-20", "last_synced_at": "2026-10-04T15:53:12.674Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01998412" }, { "nct_id": "NCT01304706", "title": "Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "Fluocinolone Acetonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alimera Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 120, "start_date": "2011-04", "completion_date": null, "has_results": true, "last_update_posted_date": "2015-05-04", "last_synced_at": "2026-10-04T15:53:12.674Z", "location_count": 1, "location_summary": "Alpharetta, Georgia", "locations": [ { "city": "Alpharetta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01304706" } ] }